Medifast Reiterated at Outperform and 4 Analyst-Reiterated Ratings to Know Now

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on November 6th.

Ligand Pharma (NASDAQ:LGND): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $22 to $25.

Medifast (NYSE:MED): Northland Securities reiterated its rating of Outperform for this company and changed its price target from $29 to $34.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Time Warner Tcom (NASDAQ:TWTC): Wunderlich reiterated its rating of Hold for this company and changed its price target from $105 to $90.

Hatteras Financial (NYSE:HTS): FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $30 to $28.

Ryder System (NYSE:R): FBR Capital reiterated its rating of Outperform for this company and changed its price target to $60.

Don’t Miss: The IMF Has This Advice for the Next U.S. President.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business